Merck and Washington University collaborate on gut bacteria research to diagnose and treat malnourished children

Foundational CRISPR patents now granted in seven markets, including Canada and Europe

Merck to sell its global Consumer Health business to Procter & Gamble (P&G) for approximately € 3.4 billion in cash

Merck and three partners start ExploreBio, a € 20 million pre-seed investment initiative in Israel

Patents in South Korea and Israel cover integration of an external DNA sequence into the chromosome of eukaryotic cells

European Patent Office (EPO) to grant patent application

Merck wants to find out if and how one can increase curiosity

Merck develops alternative CRISPR genome editing method

Phil Baran about his research and what makes a good chemist

Grzybowski Scientific Inventions (GSI)’s Chematica can design chemically viable synthetic pathways for complex targets within seconds